087sek
6,1 %
Date:2025-05-15Time:12:33:35Latest report:Q1-2025List:SpotlightTicker:ACUC
Market Cap:194 msekEnterprise Value:156 msekNet Sales:0,68 msekEarnings:-20,3 msekEmployees:0ISIN:SE0009695927

Ratios

10-year key figure history for AcuCort turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AcuCort with index and moving average MA50 and MA200.

Stockprice:0,87
MA50:0,76
MA200:0,85
Price/MA200:0,6 %
RSI (14):67,6
Price/MA50:13,8 %

Description

AcuCort is a pharmaceutical company. The company has developed and commercializes the drug Zeqmelit®, which is an oral film based on the cortisone substance dexamethasone, for quick availability and relief in severe and acute allergic reactions, among other things. The goal is commercialization in the EU, USA and in selected key markets via licensees and distributors. The company has its headquarters in Lund.

Pharmaceuticals